Evidence map›Paper›PMID 33363455›Full record

ArticleFrontiers in cellular neuroscience2020

Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis.

Marson Putra, Sreekanth Puttachary, Guanghao Liu, Gloria Lee, Thimmasettappa Thippeswamy

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Microglial MS4A4A Protects against Epileptic Seizures in Alzheimer's Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Exploring biomarkers of neurodegeneration in epilepsy: Critical insights.Epileptic disorders : international epilepsy journal with videotape · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marson PutraNeuroscience Interdepartmental Program, Iowa State University, Ames, IA, United States.
Sreekanth PuttacharyDepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Guanghao LiuDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.
Gloria LeeDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.
Thimmasettappa ThippeswamyNeuroscience Interdepartmental Program, Iowa State University, Ames, IA, United States.
Iowa State University · USUniversity of Iowa · US

Funding

TYROSINE PHOSPHORYLATION IN ALZHEIMERS DISEASER01AG017753 · NIA · UNIVERSITY OF IOWA · PI LEE, GLORIA · 1999 to 2016
$4.0M
NIA NIH HHS R01 AG017753
6 · The paper itself

Abstract

Both Fyn and tau have been associated with neuronal hyperexcitability and neurotoxicity in many tauopathies, including Alzheimer's disease (AD). Individual genetic ablation of

Indexed as

epilepsyFynneurodegenerationneuroinflammationseizuretau

Identifiers

PMID33363455
PMCPMC7752812
OpenAlexW3111993455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.